Tena SME, Herrera SD, Hernández LJ, Huicochea MJC, Rodríguez A

Language: Spanish
References: 15
Page: 99-104
PDF size: 213.98 Kb.

ABSTRACT

Introduction. Multiple familial cancer is a rare entity as is also Li-Fraumeni Syndrome (LFS), which involves a mutation in the germ cell line of Tp53 suppresor gene that is expressed in chromosome 17p13.1 and occurs as an autosomal dominant condition. Objective. Presentation of one case of LFS. Clinical case. Family history: maternal grandfather had melanoma and maternal aunt had osteoblastic osteosarcoma of the left distal femur. Eight-and-a-half year-old child with a history of a CNS tumor (choroid plexus carcinoma) and two years later, a melanoma (Spitz nevus). Symptoms: impaired motor function of the left half of the body and pain upon ipsilateral gait. The physical exam showed swelling of the left iliac crest. The X-rays showed osteoblastic osteosarcoma and the fine needle aspiration biopsy (FNAB) was positive. The diagnosis was made according to the clinical criteria for LFS. Discussion. We report a case of LFS diagnosed based on clinical criteria. We suggest that the questioning of patients with cancer be aimed at finding out the family history of neoplasias. The case presented herein shows an evident association between both choroid plexus carcinoma and osteoblastic osteosarcoma and the patient’s family history. We think that any physician treating children with cancer should consider these multiple familial cancer syndromes.

REFERENCES

1. Schneider, KA, Frederick, L: Screening for TP 53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Oncogene 2003; 22: 840-6.

2. Wunder JS, Gokgoz N, Parkes R, et al: TP53 mutations and outcome in osteosarcoma: A prospective, multicenter study. J Clin Oncology 2005; 23(7): 1483-90.

3. Garber JE, Offit K: Hereditary cancer predisposition syndromes. J Clin Oncology 2005; (23)2: 276-92.

4. Evans DG, Birch JM, Thorneycroft M, Lalloo F, Varley JM: Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome. J Med Genet 2002; 39(12): 941-4.

5. Li FP, Fraumeni JF: Prospective study of a family cancer syndrome. JAMA 1982; (247): 2692-4.

6. Birch JM, Hartley AL, Marsden HB, et al: Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. Br J Cancer 1984; (49): 325-31.

7. Birch JM, Hartley AL, Blair V, et al: Identification of factors associated with high breast cancer risk in the mothers of children with soft tissue sarcoma. J Clin Oncol 1990; (8): 583-90.

8. Fuchs B, Pritchard DJ: Etiology of osteosarcoma. Clin Orthop Relat Res 2002; (397): 40-52.

9. Franchi A, Arganini L, Baroni G, et al: Expression of transforming growth factor beta isoforms in osteosarcoma variants: Association of TGF beta 1 with high-grade osteosarcomas. J Pathol 1998; (185): 284-9.

10. Guo W, Gorlick R, Ladanyi M, et al: Expression of bone morphogenetic proteins and receptors in sarcomas. Clin Orthop 1999; (365): 175-83.

11. Bachinski L, Olufemi SE, Zhou X, Wu C, et al: Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23. Cancer Res 2005; (65): 427-31.

12. Birch JM, Alston RD, McNally RJ: Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001; (20): 4621-8.

13. Li FP, Fraumeni JF, Jr: Soft-tissue sarcomas breast cancer and other neoplasm’s: a familial syndrome? Ann Intern Med 1969; (71): 747-52.

14. Hampel H, Sweet K, Westman JA, et al: Referral for cancer genetics consultation: A review and compilation of risk assessment criteria. BMJ 2004; 41(2): 81-91.

15. Avigad S, Peleg D, Barel D, et al: Prenatal diagnosis in Li-Fraumeni syndrome. J Ped Hematol Oncol 2004; 26(9): 541-5.